Cost-Effectiveness of IDegLira Versus Insulin Intensification Regimens for the Treatment of Adults with Type 2 Diabetes in the Czech Republic

por Kvapil, Milan, Prázný, Martin, Holik, Pavel, Rychna, Karel, Hunt, Barnaby
Publicado 2017

Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi

por Pöhlmann, Johannes, Russel-Szymczyk, Monika, Holík, Pavel, Rychna, Karel, Hunt, Barnaby
Publicado 2019